Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
CytoSeek, a UK-based cancer cell therapy spinout of University of Bristol, has debuted with £1.1m ($1.4m) from investors including the Parkwalk Advisors-managed University of Bristol Enterprise Fund, Business Leader reported yesterday. The round also featured UK government-backed UK Innovation & Science Seed Fund and ten angels from Bristol Private Equity Club. CytoSeek was founded by Adam Perriman, professor of engineering at the School of Cellular and Molecular Medicine, to deliver solid tumour treatments that bind protein-based substances to immune system cells in order to help fight the disease. The funding will help CytoSeek pursue pre-clinical validation of its approach, which it says was historically restricted to treating haematological blood cancers.
Tech Launch Arizona, the tech transfer office of University of Arizona, has formed US-based ElectroSonix to take forward a non-invasive cardiac imaging technology invented by Russell Witte, professor of medical imaging, optical sciences and biomedical engineering. Witte’s approach, dubbed…
